Kim A - Search Results

1

Caspase-3 activation as a key factor for HBx-transformed cell death.

Kim A, Kwon OS, Kim SO, He L, Bae EY, Lee MS, Jeong SJ, Shim JH, Yoon DY, Kim CH, Moon A, Kim KE, Ahn JS, Kim BY. Kim A, et al. Among authors: kim ch, kim by, kim ke, kim so. Cell Prolif. 2008 Oct;41(5):755-74. doi: 10.1111/j.1365-2184.2008.00550.x. Cell Prolif. 2008. PMID: 18700866 Free PMC article.

2

Role of protein kinase C-beta isozyme in activation of latent human immunodeficiency virus type 1 in promonocytic U1 cells by phorbol-12-myristate acetate.

Kim CH, Gollapudi S, Kim A, Lee T, Gupta S. Kim CH, et al. Among authors: kim a. AIDS Res Hum Retroviruses. 1996 Sep 20;12(14):1361-6. doi: 10.1089/aid.1996.12.1361. AIDS Res Hum Retroviruses. 1996. PMID: 8891115

3

Expression of p53 protein in rheumatoid arthritis synovium. An immunohistochemical analysis.

Lee YH, Ji JD, Kim A, Kim CH, Song GG. Lee YH, et al. Among authors: kim a, kim ch. Korean J Intern Med. 1999 Jan;14(1):59-65. doi: 10.3904/kjim.1999.14.1.59. Korean J Intern Med. 1999. PMID: 10063315 Free PMC article.

4

Changes in intrinsic subtype of breast cancer during tumor progression in the same patient.

Kim C, Lee J, Lee W, Kim A. Kim C, et al. Among authors: kim a. Int J Clin Exp Pathol. 2015 Nov 1;8(11):15184-90. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26823864 Free PMC article.

5

Recurrence prediction using microRNA expression in hormone receptor positive breast cancer during tamoxifen treatment.

Kim C, Go EJ, Kim A. Kim C, et al. Among authors: kim a. Biomarkers. 2018 Dec;23(8):804-811. doi: 10.1080/1354750X.2018.1499131. Epub 2018 Aug 23. Biomarkers. 2018. PMID: 30010434

6

Examination of the Biomark assay as an alternative to Oncotype DX for defining chemotherapy benefit.

Kim J, Kim A, Kim C. Kim J, et al. Among authors: kim a, kim c. Oncol Lett. 2019 Feb;17(2):1812-1818. doi: 10.3892/ol.2018.9784. Epub 2018 Nov 30. Oncol Lett. 2019. PMID: 30675242 Free PMC article.

7

Automated immunohistochemical assessment ability to evaluate estrogen and progesterone receptor status compared with quantitative reverse transcription-polymerase chain reaction in breast carcinoma patients.

Jeon T, Kim A, Kim C. Jeon T, et al. Among authors: kim a, kim c. J Pathol Transl Med. 2021 Jan;55(1):33-42. doi: 10.4132/jptm.2020.09.29. Epub 2020 Dec 3. J Pathol Transl Med. 2021. PMID: 33260290 Free PMC article.

8

Anti-cancer effect of metformin by suppressing signaling pathway of HER2 and HER3 in tamoxifen-resistant breast cancer cells.

Kim J, Lee J, Kim C, Choi J, Kim A. Kim J, et al. Among authors: kim a, kim c. Tumour Biol. 2016 May;37(5):5811-9. doi: 10.1007/s13277-015-4440-9. Epub 2015 Nov 18. Tumour Biol. 2016. PMID: 26581908

9

Anticancer effect of metformin on estrogen receptor-positive and tamoxifen-resistant breast cancer cell lines.

Kim J, Lee J, Jang SY, Kim C, Choi Y, Kim A. Kim J, et al. Among authors: kim a, kim c. Oncol Rep. 2016 May;35(5):2553-60. doi: 10.3892/or.2016.4675. Epub 2016 Mar 11. Oncol Rep. 2016. PMID: 26986571 Free PMC article.

10

Follicular dendritic cell sarcoma arising in the dura mater of the spine.

Choi JW, Lee JH, Kim A, Kim CH, Chae YS, Kim I. Choi JW, et al. Among authors: kim a, kim ch, kim i. Arch Pathol Lab Med. 2006 Nov;130(11):1718-21. doi: 10.5858/2006-130-1718-FDCSAI. Arch Pathol Lab Med. 2006. PMID: 17076538 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,585 results

Search Page

Filters